"Mice, Inbred BALB C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research.
| Descriptor ID |
D008807
|
| MeSH Number(s) |
B01.050.050.199.520.520.338 B01.050.150.900.649.313.992.635.505.500.400.338
|
| Concept/Terms |
Mice, Inbred BALB C- Mice, Inbred BALB C
- BALB C Mouse, Inbred
- Inbred BALB C Mice
- Mouse, BALB C
- BALB C Mouse
- Mouse, Inbred BALB C
- Mice, BALB C
- BALB C Mice
- BALB C Mice, Inbred
- Inbred BALB C Mouse
|
Below are MeSH descriptors whose meaning is more general than "Mice, Inbred BALB C".
Below are MeSH descriptors whose meaning is more specific than "Mice, Inbred BALB C".
This graph shows the total number of publications written about "Mice, Inbred BALB C" by people in this website by year, and whether "Mice, Inbred BALB C" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 13 | 13 |
| 1996 | 0 | 4 | 4 |
| 1997 | 0 | 8 | 8 |
| 1998 | 0 | 11 | 11 |
| 1999 | 0 | 11 | 11 |
| 2000 | 0 | 9 | 9 |
| 2001 | 0 | 9 | 9 |
| 2002 | 0 | 8 | 8 |
| 2003 | 0 | 14 | 14 |
| 2004 | 0 | 17 | 17 |
| 2005 | 0 | 21 | 21 |
| 2006 | 0 | 19 | 19 |
| 2007 | 0 | 18 | 18 |
| 2008 | 0 | 15 | 15 |
| 2009 | 0 | 14 | 14 |
| 2010 | 0 | 10 | 10 |
| 2011 | 0 | 19 | 19 |
| 2012 | 1 | 8 | 9 |
| 2013 | 0 | 15 | 15 |
| 2014 | 0 | 7 | 7 |
| 2015 | 1 | 11 | 12 |
| 2016 | 0 | 7 | 7 |
| 2017 | 0 | 12 | 12 |
| 2018 | 0 | 14 | 14 |
| 2019 | 0 | 10 | 10 |
| 2020 | 0 | 15 | 15 |
| 2021 | 0 | 15 | 15 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mice, Inbred BALB C" by people in Profiles.
-
Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice. Front Immunol. 2022; 13:800295.
-
A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics. J Med Chem. 2022 02 24; 65(4):3420-3433.
-
Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice. Front Immunol. 2021; 12:778996.
-
Modulating donor mitochondrial fusion/fission delivers immunoprotective effects in cardiac transplantation. Am J Transplant. 2022 02; 22(2):386-401.
-
pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment. Biomed Pharmacother. 2021 Dec; 144:112317.
-
XBP-1s Promotes B Cell Pathogenicity in Chronic GVHD by Restraining the Activity of Regulated IRE-1a-Dependent Decay. Front Immunol. 2021; 12:705484.
-
Aging triggers an upregulation of a multitude of cytokines in the male and especially the female rodent hippocampus but more discrete changes in other brain regions. J Neuroinflammation. 2021 Sep 22; 18(1):219.
-
Lactic acid suppresses MRGPRX2 mediated mast cell responses. Cell Immunol. 2021 10; 368:104422.
-
In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries. Front Immunol. 2021; 12:630581.
-
Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope. J Heart Lung Transplant. 2021 10; 40(10):1112-1121.